Asclemed USA Inc. recalls
3 notices naming Asclemed USA Inc. as the recalling firm, since June 10, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Asclemed USA Inc.: Lidolog Kit
Hazard (FDA): Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
FDAMedicines
Sterility
Asclemed USA Inc.: Accucaine and 1 more
Hazard (FDA): Lack of Assurance of Sterility
FDAMedicines
Asclemed USA Inc.: Duloxetine DR Capsules
Hazard (FDA): CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
FDAMedicines